• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人参皂苷Rb1和Rg1对大鼠可逆性局灶性脑缺血的影响。

Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats.

作者信息

Zhang Y G, Liu T P

机构信息

Department of Pharmacology, Nanjing Medical University, China.

出版信息

Zhongguo Yao Li Xue Bao. 1996 Jan;17(1):44-8.

PMID:8737452
Abstract

AIM

To study the influences of ginsenosides Rb1 and Rg1 (active components of the total saponins of Panax ginseng) on the brains against ischemia-reperfusion injury.

METHODS

Rat focal cerebral ischemia was induced by reversible middle cerebral artery occlusion (MCAO) without craniectomy. The influences of ginsenoside Rb1 and Rg1 on infarct size (IS), neurologic deficit (ND) and the contents of calcium and potassium in the infarct were observed.

RESULTS

In a 2-h ischemia, Rb1 10-40 mg.kg-1 i.v. 30 min before MCAO decreased IS by 20%-49% and ND score from 5.1 to 4.1-2.3, and inhibited Ca accumulation and K loss by 22%-50% and 18-37%, respectively; Rb1 10-40 mg.kg-1 i.v. immediately after MCA was recanalized decreased IS by 12%-35% and ND score from 5.2 to 4.3-3.3, and inhibited Ca accumulation and K loss by 10%-40% and 17%-30%, respectively. In permanent ischemia, Rb1 40 mg.kg-1 i.v. reduced IS, ND, Ca accumulation and K loss. However, Rg1 40 mg.kg-1 i.v. did not show effect on both permanent and 2-h MCAO.

CONCLUSIONS

Rb1 protected brain from ischemic and reperfusion injuries.

摘要

目的

研究人参皂苷Rb1和Rg1(人参总皂苷的活性成分)对脑缺血再灌注损伤的影响。

方法

采用可逆性大脑中动脉闭塞(MCAO)法制备大鼠局灶性脑缺血模型,不进行开颅手术。观察人参皂苷Rb1和Rg1对梗死体积(IS)、神经功能缺损(ND)以及梗死灶内钙和钾含量的影响。

结果

在2小时缺血模型中,MCAO前30分钟静脉注射10 - 40mg·kg-1的Rb1可使IS降低20% - 49%,ND评分从5.1降至4.1 - 2.3,并分别抑制钙蓄积和钾丢失22% - 50%和18% - 37%;MCA再通后立即静脉注射10 - 40mg·kg-1的Rb1可使IS降低12% - 35%,ND评分从5.2降至4.3 - 3.3,并分别抑制钙蓄积和钾丢失10% - 40%和17% - 30%。在永久性缺血模型中,静脉注射40mg·kg-1的Rb1可减少IS、ND、钙蓄积和钾丢失。然而,静脉注射40mg·kg-1的Rg1对永久性和2小时MCAO均无作用。

结论

Rb1可保护脑免受缺血和再灌注损伤。

相似文献

1
Influences of ginsenosides Rb1 and Rg1 on reversible focal brain ischemia in rats.人参皂苷Rb1和Rg1对大鼠可逆性局灶性脑缺血的影响。
Zhongguo Yao Li Xue Bao. 1996 Jan;17(1):44-8.
2
[Protective effects of Panax notoginseng saponins on experimental myocardial injury induced by ischemia and reperfusion in rat].
Zhongguo Yao Li Xue Bao. 1990 Jan;11(1):26-9.
3
Effects of the Combination of the Main Active Components of Astragalus and Panax notoginseng on Inflammation and Apoptosis of Nerve Cell after Cerebral Ischemia-Reperfusion.黄芪和三七主要活性成分组合对脑缺血再灌注后神经细胞炎症和凋亡的影响
Am J Chin Med. 2015;43(7):1419-38. doi: 10.1142/S0192415X15500809. Epub 2015 Oct 18.
4
Neuroprotective Effects of Ginsenosides against Cerebral Ischemia.人参皂苷对脑缺血的神经保护作用。
Molecules. 2019 Mar 20;24(6):1102. doi: 10.3390/molecules24061102.
5
Comparative analysis of the neuroprotective effects of ginsenosides Rg1 and Rb1 extracted from Panax notoginseng against cerebral ischemia.三七中提取的人参皂苷 Rg1 和 Rb1 对脑缺血的神经保护作用比较分析。
Can J Physiol Pharmacol. 2014 Feb;92(2):102-8. doi: 10.1139/cjpp-2013-0274. Epub 2014 Jan 14.
6
[Effect of ginsenoside Rb1 on cerebral infarction volume and IL-1 beta in the brain tissue and sera of focal cerebral ischemia/reperfusion injury model rats].人参皂苷Rb1对局灶性脑缺血/再灌注损伤模型大鼠脑组织及血清中脑梗死体积和白细胞介素-1β的影响
Zhongguo Zhong Xi Yi Jie He Za Zhi. 2013 Dec;33(12):1696-700.
7
Effects of ginsenosides on Ca2+ channels and membrane capacitance in rat adrenal chromaffin cells.人参皂苷对大鼠肾上腺嗜铬细胞中Ca2+通道和膜电容的影响。
Brain Res Bull. 1998 Jun;46(3):245-51. doi: 10.1016/s0361-9230(98)00014-8.
8
Inhibitory effects of ginsenoside Rg1 and Rb1 on rat brain microsomal Na+,K(+)-ATPase activity.人参皂苷Rg1和Rb1对大鼠脑微粒体Na +,K(+)-ATP酶活性的抑制作用。
Zhongguo Yao Li Xue Bao. 1990 Jan;11(1):10-4.
9
[Protective effects of ginsenoside Rb1 and Rg1 on cultured hippocampal neurons].人参皂苷Rb1和Rg1对培养海马神经元的保护作用
Yao Xue Xue Bao. 1995;30(9):674-8.
10
Effects of saponins of Panax notoginseng on sodium-potassium-adenosine triphosphatase and calcium-magnesium-adenosine triphosphatase.
Zhongguo Yao Li Xue Bao. 1991 Nov;12(6):504-6.

引用本文的文献

1
A 12-week, randomized, double-blind study to evaluate the efficacy and safety of liver function after using fermented ginseng powder (GBCK25).一项为期12周的随机双盲研究,旨在评估使用发酵人参粉(GBCK25)后肝功能的疗效和安全性。
Food Nutr Res. 2020 Apr 6;64. doi: 10.29219/fnr.v64.3517. eCollection 2020.
2
Efficacy and Mechanism of Panax Ginseng in Experimental Stroke.人参在实验性中风中的疗效及机制
Front Neurosci. 2019 Apr 24;13:294. doi: 10.3389/fnins.2019.00294. eCollection 2019.
3
Ginseng: a promising neuroprotective strategy in stroke.
人参:脑卒中神经保护的有前途策略。
Front Cell Neurosci. 2015 Jan 20;8:457. doi: 10.3389/fncel.2014.00457. eCollection 2014.
4
A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system.人参及人参皂苷在中枢神经系统的治疗和药理学作用的全面综述。
J Ginseng Res. 2013 Mar;37(1):8-29. doi: 10.5142/jgr.2013.37.8.
5
Active ingredients in Chinese medicines promoting blood circulation as Na+/K+ -ATPase inhibitors.具有促进血循环作用的中药的有效成分是 Na+/K+-ATP 酶抑制剂。
Acta Pharmacol Sin. 2011 Feb;32(2):141-51. doi: 10.1038/aps.2010.197.
6
Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study.西洋参(Panax quinquefolius)对神经认知功能的影响:一项急性、随机、双盲、安慰剂对照、交叉研究。
Psychopharmacology (Berl). 2010 Oct;212(3):345-56. doi: 10.1007/s00213-010-1964-y. Epub 2010 Jul 31.
7
The neuroprotective effect of methanol extract of gagamjungjihwan and fructus euodiae on ischemia-induced neuronal and cognitive impairment in the rat.加麻金珠煎剂和吴茱萸果实甲醇提取物对大鼠缺血诱导的神经元和认知功能障碍的神经保护作用。
Evid Based Complement Alternat Med. 2011;2011:685254. doi: 10.1093/ecam/nep028. Epub 2011 Mar 10.
8
Effect of sugar positions in ginsenosides and their inhibitory potency on Na+/K+-ATPase activity.人参皂苷中糖基位置对其抑制Na+/K+-ATP酶活性的影响及其抑制效力
Acta Pharmacol Sin. 2009 Jan;30(1):61-9. doi: 10.1038/aps.2008.6. Epub 2008 Dec 8.